Daniel Lindén

4.6k citations
61 papers · 3.5k · 4 hit papers · h-index 35

Impact in

    • Lipid metabolism and biosynthesis
    • Liver Disease Diagnosis and Treatment
    • Adipokines, Inflammation, and Metabolic Diseases

Papers in

Daniel Lindén

61 papers receiving 3.4k citations

Daniel Lindén's Hit Papers

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials 2025 · 46 citations
460+1+2Years since publication50100150

Peers

Daniel Lindén
Comparison fields: 5 of 101
  • Biochemistry 300
  • Epidemiology 1.4k
  • Endocrine and Autonomic Systems 118
  • Hepatology 159
  • Endocrinology, Diabetes and Metabolism 259
Replace Isabelle Hainault with:
Isabelle Hainault France
Zhouji Chen United States
Xiaorong Fu United States
Daniel F. Vatner United States
Tim Rolph United States
Shannon M. Reilly United States
Suneng Fu China
Myoung Sook Han United States
Paul M. Titchenell United States
Jachelle M. Ofrecio United States
Daniel Lindén relative to Isabelle Hainault France Isabelle Hainault's profile →
Citations per field
00.5×2×4×6.4×
Isabelle Hainault · 1×
Citations per year

Countries citing papers authored by Daniel Lindén

Since Specialization
Citations

This map shows the geographic impact of Daniel Lindén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lindén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lindén more than expected).

Fields of papers citing papers by Daniel Lindén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lindén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lindén. The network helps show where Daniel Lindén may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Lindén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Lindén Line = papers co-authored together Daniel Lindén links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007228
2 2019184
3 2017165
4
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
Hit paper breakdown →
2023158
5 2020145
6
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Hit paper breakdown →
2024142
7 2006136
8 2019121
9 2002116
10 2004116
11 2006107
12 2021107
13 2019100
14 202393
15 200490
16 200583
17 200280
18 201973
19 200571
20 202369

About Daniel Lindén

Daniel Lindén is a scholar working on Epidemiology, Endocrine and Autonomic Systems, Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 61 papers that have together received 3.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Regulation of Appetite and Obesity (6 papers), Lipid metabolism and biosynthesis (5 papers), Cholesterol and Lipid Metabolism (5 papers), Lipid metabolism and disorders (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Biochemistry (300 citations), Epidemiology (1.4k citations), Endocrine and Autonomic Systems (118 citations), Hepatology (159 citations) and Endocrinology, Diabetes and Metabolism (259 citations). Daniel Lindén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Jan Oscarsson, Stefano Romeo, Mikael Bjursell, Lena William‐Olsson, Mohammad Bohlooly‐Y, Andrea Ahnmark, Anna Ljungberg, Lennart Asp, Caroline Améen and Sven‐Olof Olofsson. Their work appears in journals such as American Journal of Physiology-Endocrinology and Metabolism, Liver International, Journal of Lipid Research, PLoS ONE and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact